Mohnark Pharmaceuticals recalls lidocaine topical anesthetic cream

Photo source: CPSC

The product's packaging is not child-resistant

Mohnark Pharmaceuticals of Davie, Fla., is recalling about 9,000 tubes of Lidocaine 4% Topical Anesthetic Cream.

The product's packaging is not child-resistant as required by the Poison Prevention Packaging Act. This poses a risk of poisoning to young children if they ingest the anesthetic cream.

No incidents or injuries have been reported.

The recall involves Mohnark Pharmaceuticals Lidocaine 4% Topical Anesthetic Cream sold in a white tube with a flip-top closure.

Mohnark Pharmaceuticals is printed under the blue and green logo on the right side of the product tube. The lot code is located at the bottom of the product tube. The affected lot codes are 01202201, 210201, 210301, 210503, 210505, 210601, 211002 and 210401. The UPC 860002324906 is located on the bottom side panel of the packaging.

The anesthetic cream, manufactured in the U.S., was sold online at and from January 2021, through January 2022, for about $7.

What to do

Consumers should immediately stop using the recalled cream and store it in a location that is out of the sight and reach of children. Customers can contact Mohnark Pharmaceuticals for instructions on how to dispose of the product to receive a full refund.

Mohnark Pharmaceuticals is contacting all known purchasers directly.

Consumers may contact Mohnark Pharmaceuticals toll-free at (866) 611-5206 from 9 a.m. to 4 p.m. (ET) Monday through Friday or online for more information.

Take a Home Warranty Quiz. Get matched with an Authorized Partner.